| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |